https://www.selleckchem.com/pr....oducts/d-lin-mc3-dma
The incidence of breast cancer (BC) in LMICs has increased by more than 20% within the last decade. In areas such as Latin America (LA), addressing BC at national levels evoke discussions surrounding fragmented care, limited resources, and regulatory barriers. Precision Medicine (PM), specifically companion diagnostics (CDx), links disease diagnosis and treatment for better patient outcomes. Thus, its application may aid in overcoming these barriers. A panel of LA experts in fields related to BC and PM were provided with a series
Like
Comment
Share
